This report provides a direct comparison of Non-Small Cell Lung Cancer Treatment Options: New Zealand and Australia versus European Society for Medical Oncology (ESMO) Guidelines. Sadly this report demonstrates how far behind Pharmac is with reimbursing standard of care treatments for NZ’s Biggest Cancer Killer and why lung cancer patients die prematurely in New Zealand. […]
Lung Cancer
Transcript of Guyon Espiner’s interview of Pharmac, CEO, Sarah Fitt
“There are more than a hundred medicines on the PHARMAC waiting list. Some have been there five, ten or even fifteen years. I interviewed the Chief Executive of PHARMAC, Sarah Fitt, and asked her whether she was comfortable with that. Well, if there’s other medicines that have come along and replaced it. If there’s not […]
Infographic shows why lung cancer patients are dying prematurely
New Zealand is so far behind with access to standard of care treatments it is embarrassing. Lung cancer is the most targetable cancer. However, Pharmac policy is causing our most vulnerable to die prematurely.
MARCH WITH US to DELIVER our PETITION to PARLIAMENT IN TRIBUTE to COURAGEOUS AMBASSADOR, JASON GUTTENBEIL.
WHEN: Tuesday 7 May 2019 10.45 am to 1.00 pm WHERE: Meet at the courtyard, outside Wellington Library, 65 Victoria Street. We will march to Pharmac at 40 Mercer Street, then along Willis Street and Lambton Quay, before arriving on the steps of Parliament. Click the link to view our poster – LFNZ Petition Submission […]
Staggering imbalance with cancer treatments funded by Pharmac
Despite lung cancer being NZ’s Biggest Cancer Killer, the top 3 lung cancer drugs funded by Pharmac (2017/18) equates to just 2.3% of the top 5 cancer drugs ($122 million). Click to view PDF –
Sign our Petition
Please stand with us by signing this petition. Together we can call on the Government to declare lung cancer a health priority and to approve additional budget for Pharmac to fund lung cancer medications, including Keytruda, Alectinib, Osimertinib and Crizotinib, for all Kiwis with advanced lung cancer, irrespective of socio-economic status. https://www.parliament.nz/en/pb/petitions/document/PET_86322/petition-of-philip-hope-for-lung-foundation-new-zealand?fbclid=IwAR0Er6gNod70xvpB1kq3bBVa0LExrfq8GSWo7Gv3KvV-Jr9vwb8mL-NsrDs
Submission to Pharmac – includes letters from lung cancer patients
Lung Foundation NZ has filed a submission with Pharmac, urging them to do better for lung cancer – NZ’s Biggest Cancer Killer. A staggering imbalance exists, because of underfunding by Pharmac. For example; the top 3 lung cancer drugs reimbursed in NZ, represents less than 3% of the top 5 cancer drugs funded, despite lung […]
Courageous mother of two talks about her lung cancer journey
Christine Roberts, 51, was diagnosed with stage four lung cancer in May 2017. This brave mother talks about her challenging cancer journey and her children. Christine has a message for Pharmac which is an instrument of government. http://https://drive.google.com/file/d/1QwSf4swQXLDNA4M9qVmUHhsuZNv0lsU-/view
National lung cancer screening programme could save kiwi lives
The introduction of a lung cancer screening programme has the potential to improve health outcomes in New Zealand for NZ’s Biggest Cancer Killer. Data from the NELSON study which was presented at last year’s International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (to which Lung Foundation NZ is affiliated) […]
A new approach, informed by equity needed for lung cancer
Dr Chris Atkinson, Lung Foundation NZ, Medical Director & Associate Professor of Oncology A new approach, informed by equity, a must to improve outcomes for lung cancer – NZ biggest cancer killer. Watch our video here
